Efficacy and Safety of Simplified SGLT2i-Based Stepwise Intensive Therapy in Inducing Diabetes Remission in Newly Diagnosed Type 2 Diabetes with Severe Hyperglycemia: A Pilot Study
by Prateek Chopra | June 26, 2026 | Diabetes Conferences | ADA 2026 Study Objective Methods Primary Endpoint Study Population Remission Outcomes Metabolic Outcomes Safety SGLT2i-based stepwise intensive therapy achieved remission rates comparable to conventional SIT while providing greater improvements in insulin sensitivity and BMI. This simplified outpatient-oriented approach may offer a practical alternative to prolonged inpatient intensive insulin therapy […]